BPC-157 and TB-500 Dosage Protocol BPC-157: 250500mcg daily, injected subcutaneously near the injury site TB-500: 22.5mg twice weekly (loading phase) for 46 weeks, then 2mg once weekly (maintenance phase) The combination is typically used for 612 weeks, depending on injury severity and healing progress
This is why testing before supplementing saves both money and effort
Where serum B12 results are borderline or do not fit the clinical picture, further tests such as active B12 (holotranscobalamin), methylmalonic acid, or homocysteine may be helpful
"BPC 157 and standard angiogenic growth factors: Gastrointestinal tract healing, lessons learned from tendon, ligament, muscle and bone healing." Current Pharmaceutical Design
GHK-Cu 50mg The GHK-Cu portion contributes a substantial 10mg GHK Cu equivalent concentration within the copper peptide complex, forming part of the larger GHK-Cu content